The Mectizan Donation Program is an international initiative aimed at eradicating river blindness and lymphatic filariasis (LF), supported primarily by Merck Co., Inc. and GSK. Mectizan, provided by Merck, is administered in conjunction with albendazole, donated by GSK, to combat LF. The program operates globally, working to eliminate these debilitating diseases and improve the health and well-being of affected communities.
The Mectizan Donation Program, headquartered in Decatur, Georgia, USA, is dedicated to the elimination of river blindness and LF. With the support of Merck and GSK, the program distributes Mectizan and albendazole to communities worldwide, targeting the prevention and treatment of these diseases. Through its partnerships and coordinated efforts, the program strives to make a lasting impact on the lives of those affected by river blindness and LF.
Generated from the website